Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: A differential expression study

Cancer

Volumn 103, Issue 2, 2005, Pages 268-276

  Fong, Pui Yee ^a   Xue, Wei Cheng ^a   Ngan, Hextan Y S ^a   Chan, Kelvin Y K ^a   Khoo, Ui Soon ^a   Tsao, Siu Wah ^a   Chiu, Pui Man ^a   Man, Lai Shan ^a   Cheung, Annie N Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

c DNA array; Gestational trophoblastic disease; Hydatidiform mole; Mcl 1

Indexed keywords

CIRCULAR DNA; PROTEIN MCL 1;

ADULT; APOPTOSIS; ARTICLE; CANCER REGRESSION; CANCER STAGING; CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; GENE IDENTIFICATION; GESTATION PERIOD; HUMAN; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TROPHOBLASTIC DISEASE;

ADOLESCENT; ADULT; BASE SEQUENCE; BIOPSY, NEEDLE; COHORT STUDIES; DISEASE PROGRESSION; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LOGISTIC MODELS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PREGNANCY; PROBABILITY; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 12344276322     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20767     Document Type: Article

References (49)

1. Shih IM, Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesion. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. New York: Springer Verlag, 2002:1193-1247.
2. Paradinas FJ, Elston CW. Gestational trophoblastic diseases. In: Fox H, Wells M, editors. Haines and Taylor obstetrical and gynaecological pathology. Edinburgh: Churchill Livingstone, 2003:1359-1430.
3. Cheung AN. Pathology of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol. 2003;17:849-868.
4. Wong LC, Ngan HYS, Cheng DKL, Ng TY. Methotrexate infusion in low-risk gestational trophoblastic disease. Am J Obstet Gynecol. 2000;183:1579-1582.
5. Zhao N, Hashida H, Takahashi N, et al. High density cDNA filter analysis: a novel approach for large-scale quantitative analysis of gene expression. Gene. 1995;156:207-213.
6. DeRisi J, Penland L, Brown PO, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet 1996;14:457-460.
7. Heller RA, Schena M, Chai A, et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA. 1997;94:2150-2155.
8. Shim C, Zhang W, Rhee CH, Lee JH. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin Cancer Res. 1998;4:3045-3050.
9. Lander ES. Array of hope. Nature Genet. 1999;21(Suppl):3-4.
10. Feng HC, Cheung ANY, Xue WC, et al. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 (TIMP3) in choriocarcinoma. Gynecol Oncol. 2004;94:375-382.
11. Cheung ANY, Zhang DK, Liu Y, Ngan HY, Shen DH, Tsao SW. Telomerase activity in gestational trophoblastic disease. J Clin Pathol. 1999;52:588-592.
12. Wong SYY, Ngan HY, Chan CC, Cheung ANY. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and bcl-2 expression but not bax expression. Mol Pathol. 1999;12:1025-1033.
13. Chiu PM, Ngan YS, Khoo US, Cheung ANY. Apoptotic activity in gestational trophoblast disease correlates with clinical outcome: assessment by the caspase-related M30 cytoDeath antibody. Histopathology. 2001;38:243-249.
14. Lai CY, Chan KY, Khoo US, et al. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod Pathol. 2004;17:40-48.
15. Cheung ANY, Khoo US, Lai CYL, et al. Metastatic trophoblastic disease following initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cancer. 2004;100:1411-1417.
16. Liu SS, Cheung AN, Ngan HY. Differential gene expression in cervical cancer cell lines before and after ionizing radiation. Int J Oncol. 2003;22:1091-1099.
17. Bae J, Leo CP, Hsu SY, Hsueh AJW. Mcl-1s, a splicing variant of the antiapoptotic bcl-2 family member mcl-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem. 2000;275:25255-25261.
18. Chan KY, Ozcelik H, Cheung AN, Ngan HY, Khoo US. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res. 2002;62:4151-4156.
19. Xue WC, Feng HC, Tsao SW, et al. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases. Int J Gynaecol Cancer. 2003;13:879-888.
20. Li R, Tsao GSW, Cheung ANY. Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta. 2002;23:20-31.
21. Yang X, Zhang Z, Jia C, Li J, Yin L, Jiang S. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole. Gynecol Oncol. 2002;85:438-444.
22. Kim YT, Cho NH, Ko JH, et al. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts. Cancer. 2000;89:673-679.
23. Fulop V, Colitti CV, Genest D, et al. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene. 1998;17:419-424.
24. Stahle-Backdhal M, Inoue M, Zedenius J, et al. Decreased expression of Ras GTPase activating protein in human trophoblastic tumors. Am J Pathol. 1995;146:1073-1078.
25. Vegh GL, Fulop V, Liu Y, et al. Differential gene expression pattern between normal human trophoblast and choriocarcinoma cell lines: downregulation of heat shock protein-27 in choriocarcinoma in vitro and in vivo. Gynecol Oncol. 1999;75:391-396.
26. Batorfi J, Ye B, Mok SC, Cseh I, Berkowitz RS, Fulop V. Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol Oncol. 2003;88:424-428.
27. Kato HD, Terao Y, Ogawa M, et al. Growth-associated gene expression profiles by microarray analysis of trophoblast of molar pregnancies and normal villi. Int J Gynecol Pathol. 2002;21:255-260.
28. Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell. 2000;102:1-4.
29. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
30. Hockenbery D, Milliman C, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334-336.
31. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA. 1993;90:3516-3520.
32. Reed JC. Bcl-2 family proteins. Oncogene. 1998;17:3225-3236.
33. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124:1-6.
34. Krajewski S, Bodrug S, Krajewska M, et al. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol. 1995;146:1309-1319.
35. Krajewska M, Krajewski S, Ehrmann J, et al. Immunohistochemical analysis of bcl-2, bax, bcl-1 and mcl-1 expression in prostate cancers. Am J Pathol. 1996;148:1567-1576.
36. Miyamoto Y, Hosotani R, Rada M, et al. Immunohistochemical analysis of bcl-2, bax, bcl-x and mcl-1 expression in pancreatic cancers. Oncology. 1999;56:73-82.
37. Chen FF, Yan JJ, Chang KC, Lai WW, Chen RM, Jin YT. Immunohistochemical localization of mcl-1 and bcl-2 proteins in thymic epithelial tumors. Histopathology. 1996;29:541-547.
38. Dorfman DM, Shahsafaei A, Miyauchi A. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma(ITEI)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma. Mod Pathol. 1998;11:989-994.
39. Wehrli BM, Krajewski S, Gascoyne RD, Reed JC, Gilks CB. Immunohistochemical analysis of bcl-2, bax, mcl-1, and bcl-X expression in ovarian surface epithelial tumors. Int J Gynecol Pathol. 1998;17:225-260.
40. Allal AS, Waelchli L, Brundler MA. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma. Clin Cancer Res. 2003;9:6489-6496.
41. Cheung ANY, Ngan HYS, Chen WZ, Loke SL, Collins RJ. The significance of proliferating cell nuclear antigen in human trophoblastic disease - an immunohistochemical study. Histopathology. 1993;22:565-568.
42. Cheung ANY, HYS Ngan, Collins RJ, Wong YL. Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen. J Clin Pathol. 1994;47:601-604.
43. Xue WC, Khoo US, Ngan HY, et al. Minichromosome maintenance protein 7 expression in gestational trophoblastic disease: correlation with Ki67, PCNA and clinicopathologic parameters. Histopathology. 2003;43:485-490.
44. Huppertz B, Frank HG, Kingdom JCP, Reister F, Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in human placenta. Histochem Cell Biol. 1998,110:495-508.
45. Huppertz B, Frank HG, Reister F, Kingdom J, Korr H, Kaufmann P. Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab Invest. 1999,79:1687-1702.
46. Cheung ANY, Srivastava G, Pittaluga S, Man TK, Ngan H, Collins RJ. Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta. J Clin Pathol. 1993;46:204-207.
47. Cheung ANY, Shen DH, Khoo US, et al. Immunohistochemical and mutational analysis of p53 tumor suppressor gene in gestational trophoblastic disease-correlation with mdm2, proliferation index and clinicopathological parameters. Int J Gynecol Cancer. 1999;9:123-130.
48. WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters and Ki67 and p53 gene expression. J Clin Pathol. 1998;51:159-162.
49. Suzuki A, Umezawa A, Sano M, Nozawa S, Hata J. Involvement of EAT/mcl-1, a bcl-2 related gene, in the apoptotic mechanisms underlying human placental development and maintenance. Placenta. 2000;21:177-183.